Six years ago, we proposed a patient benefit-centered definition of medical futility that included both quantitative and qualitative components.
We distinguished between an effect of a treatment that is limited to some part of a patient's body and a benefit that improves the patient as a whole.
The quantitative portion of our definition stipulated that physicians should regard a treatment as futile if empirical data show that the treatment has less than a 1 in 100 chance of benefiting the patient.
The qualitative portion of our definition stipulated that if a treatment merely preserves permanent unconsciousness or cannot end dependence on intensive medical care, physicians should consider the treatment futile. (...)
Mots-clés Pascal : Relation médecin malade, Traitement, Chimiothérapie, Analyse risque, Indication, Homme
Mots-clés Pascal anglais : Physician patient relation, Treatment, Chemotherapy, Risk analysis, Indication, Human
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 96-0493488
Code Inist : 002B30A05. Création : 10/04/1997.